Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHansard Regulatory News (HSD)

Share Price Information for Hansard (HSD)

Share Price is delayed by 15 minutes
Get Live Data
52.00    1.40 (2.77%)
Bid:
50.00
Ask:
52.00
Spread: 2.00 (4.00%)
Market Cap: £71.00m
HSD Live PriceLast checked at - London Stock Exchange

Intraday Hansard Share Chart

Holding(s) in Company

29 Oct 2025 07:00

RNS Number : 1733F
Hansard Global plc
29 October 2025
Β 

Hansard Global Plc (the "Company")

Β 

Β 

Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Persons Closely Associated with them in accordance with article 19 of the Market Abuse Regulation

Details of the full notifications received by the Company are set out below.

1.

Details of PDMR/PCA

a)

Name

The Polonsky Foundation (PCA)

2.

Reason for the notification

a)

Position / status

Notification concerns a person closely associated with Marc Polonsky, Non-Executive Director

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hansard Global Plc

b)

LEI

213800ZJ9F2EA3Q24K05

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Β 

Ordinary shares of 50 pence each

Identification Code

ISIN: IM00B1H1XF89

b)

Nature of the transaction

Transfer of shares from the Leonard Polonsky Revocable Trust to The Polonsky Foundation following the death of Dr Leonard Polonsky, in accordance with terms of the Leonard Polonsky Revocable Trust.

c)

Price(s) and volume(s)

Β 

Β 

Price(s)

Volume(s)

Nil

49,946,319

d)

Aggregated information:

Aggregated volume

Price

N/A (single transaction)

e)

Date of the transaction

27 October 2025

f)

Place of the transaction

Outside a trading venue

Β 

Β 

1.

Details of PDMR/PCA

a)

Name

The Leonard Polonsky Revocable Trust (PCA)

2.

Reason for the notification

a)

Position / status

Notification concerns a person closely associated with Marc Polonsky, Non-Executive Director

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hansard Global Plc

b)

LEI

213800ZJ9F2EA3Q24K05

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Β 

Ordinary shares of 50 pence each

Identification Code

ISIN: IM00B1H1XF89

b)

Nature of the transaction

Transfer of shares from the Leonard Polonsky Revocable Trust to The Polonsky Foundation following the death of Dr Leonard Polonsky, in accordance with terms of the Leonard Polonsky Revocable Trust.

c)

Price(s) and volume(s)

Β 

Β 

Price(s)

Volume(s)

Nil

49,946,319

d)

Aggregated information:

Aggregated volume

Price

N/A (single transaction)

e)

Date of the transaction

27 October 2025

f)

Place of the transaction

Outside a trading venue

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TR-1: Standard form for notification of major holdings

Β 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

Hansard Global plc

1b. Please indicate if the issuer is a non-UK issuerΒ  (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii: Transfer of Shares from the Leonard Polonsky Revocable Trust to The Polonsky Foundation following the death of Dr Leonard Polonsky, in accordance with terms of the Leonard Polonsky Revocable Trust.

x

3. Details of person subject to the notification obligation iv

Name

THE POLONSKY FOUNDATION

City and country of registered office (if applicable)

London, England

4. Full name of shareholder(s) (if different from 3.) v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached vi:

27/10/2025

6. Date on which issuer notified (DD/MM/YYYY):

29/10/2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

42.52

42.52

58,494,027

Position of previous notification (if

applicable)

6.21

6.21

Β 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

Β (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

IM00B1H1XF89

ORDINARY

58,494,027

42.52

SUBTOTAL 8. A

58,494,027

42.52

Β 

Β 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

N/A

SUBTOTAL 8. B 1

Β 

Β 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

N/A

Β 

SUBTOTAL 8.B.2

Β 

Β 

Β 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Β 

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

Β 

Place of completion

London, UK

Date of completion

Β 27 October 2025

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TR-1: Standard form for notification of major holdings

Β 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

Hansard Global plc

1b. Please indicate if the issuer is a non-UK issuerΒ  (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii: Transfer of Shares from the Leonard Polonsky Revocable Trust to The Polonsky Foundation following the death of Dr Leonard Polonsky, in accordance with terms of the Leonard Polonsky Revocable Trust.

x

3. Details of person subject to the notification obligation iv

Name

LEONARD POLONSKY REVOCABLE TRUST

City and country of registered office (if applicable)

London, England

4. Full name of shareholder(s) (if different from 3.) v

Name

DR LEONARD SELWYN POLONSKY LPRT

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached vi:

Β 27/10/2025

6. Date on which issuer notified (DD/MM/YYYY):

Β 29/10/2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

0.00

0.00

0.00

Position of previous notification (if

applicable)

36.31

36.31

Β 

Β 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

Β (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

IM00B1H1XF89

ORDINARY

0

0.00

SUBTOTAL 8. A

0

0.00

Β 

Β 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

N/A

SUBTOTAL 8. B 1

Β 

Β 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

N/A

Β 

SUBTOTAL 8.B.2

Β 

Β 

Β 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Β 

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

Β 

Place of completion

London, UK

Date of completion

Β 27 October 2025

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
HOLEAKEPAALSFFA
Date   Source Headline
20th Mar 20263:21 pmRNSInsurance Recovery Received
5th Mar 20267:00 amRNSInterim Results
5th Nov 202511:29 amRNSResult of AGM
29th Oct 20257:00 amRNSHolding(s) in Company
2nd Oct 20258:48 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSResults for the year ended 30 June 2025
24th Jul 20257:00 amRNSDirectorate Change
17th Mar 20257:00 amRNSDr Leonard Polonsky
6th Mar 20257:00 amRNSInterim Result
17th Dec 20247:00 amRNSDirectorate Change
28th Nov 20247:00 amRNSDirectorate Change
13th Nov 202412:00 pmRNSResult of AGM
22nd Oct 20247:00 amRNSBlock listing Interim Review
2nd Oct 20247:00 amRNSAppointment of Chief Financial Officer
26th Sep 20247:00 amRNSResults for the year ended 30 June 2024
24th Sep 20247:00 amRNSDirectorate Change
2nd Aug 20247:00 amRNSDirectorate Change
1st Jul 20248:46 amRNSTR-1 Notification of Major Holdings
27th Jun 20247:00 amRNSDistribution Agreement
22nd Apr 20249:36 amRNSBlock listing Interim Review
7th Mar 20247:05 amRNSResults for the six months ended 31 December 2023
15th Feb 20247:00 amRNSDirectorate Change
8th Nov 202311:55 amRNSResult of AGM
23rd Oct 20237:24 amRNSBlock listing Interim Review
28th Sep 202311:42 amRNSResults for the year ended 30 June 2023
28th Sep 20237:00 amRNSResults for the year ended 30 June 2023
27th Jul 20237:00 amRNSNew business results for the year ended 30/06/2023
23rd May 20239:27 amRNSDirector/PDMR Shareholding
4th May 20237:00 amRNSTrading Statement
20th Apr 20233:01 pmRNSBlock listing Interim Review
9th Mar 20237:00 amRNSResults for the six months ended 31 December 2022
26th Jan 20237:00 amRNSNew business results for 6 months ended 31/12/22
23rd Jan 20237:00 amRNSDirectorate Change
23rd Nov 20227:00 amRNSDirectorate Change
3rd Nov 20227:00 amRNSTrading update for the quarter ended 30/09/2022
2nd Nov 202212:22 pmRNSResult of AGM
25th Oct 20224:41 pmRNSSecond Price Monitoring Extn
25th Oct 20224:36 pmRNSPrice Monitoring Extension
20th Oct 202211:18 amRNSBlock listing Interim Review
5th Oct 20224:36 pmRNSPrice Monitoring Extension
26th Sep 20224:41 pmRNSSecond Price Monitoring Extn
26th Sep 20224:36 pmRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSResults for the year ended 30 June 2022
21st Jul 20227:00 amRNSNew business results for the year ended 30/06/2022
20th May 202211:59 amRNSPDMR Shareholding
5th May 20227:00 amRNSTrading update for the period ended 31 March 2022
22nd Apr 20228:30 amRNSBlock listing Interim Review
25th Mar 20229:54 amRNSListing Rule 9.6.14(R) Disclosure
3rd Mar 20227:05 amRNSAppointment of Chairman
3rd Mar 20227:00 amRNSResults for the six months ended 31 December 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.